Leveraging Immunotherapy in Acute Myeloid Leukemia Treatment: Opportunities and Challenges
Acute myeloid leukemia (AML) is a heterogeneous group of malignant clonal disorders originating from hematopoietic stem or progenitor cells. Despite significant advances in understanding its pathogenesis and the development of novel therapeutic agents, the overall prognosis for AML patients remains...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2026-07-01
|
| Sarja: | Technology in Cancer Research & Treatment |
| Linkit: | https://doi.org/10.1177/15330338261473431 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|